This inventor holds 1 USPTO granted patent. Top assignee: Novartis Pharma Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Andrew Green and Patent Innovation at Novartis Pharma AG.
Introduction
Andrew Green is an inventor associated with Basel, US, and Novartis Pharma AG. His patent work includes an invention concerning reversal binding agents for anti-factor XI/XIa antibodies.
Latest Patents
Green is credited with 1 patent: “Reversal Binding Agents for Anti-Factor XI/XIa Antibodies and Uses Thereof.” The patent addresses agents designed to reverse the effects of anti-factor XI/XIa antibodies and their potential uses.
Career Highlights
Green’s listed patent connects his work with pharmaceutical research and the development of antibody-related technologies at Novartis Pharma AG.
Collaborations
His listed coworkers include Stefan Ewert and Alexander Wolfgang Koch.
Conclusion
Andrew Green’s patent record highlights his contribution to pharmaceutical innovation through research on reversal agents for anti-factor XI/XIa antibodies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile